Dittrich Julia, Ceglarek Uta
Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Paul-List-Str. 13-15, Leipzig, 04103, Germany.
LIFE-Leipzig Research Center for Civilization Diseases, Leipzig University, Philipp-Rosenthal-Str. 27, Leipzig, Germany.
Methods Mol Biol. 2017;1619:417-430. doi: 10.1007/978-1-4939-7057-5_29.
The increasing number of peptide and protein biomarker candidates requires expeditious and reliable quantification strategies. The utilization of liquid chromatography coupled to quadrupole tandem mass spectrometry (LC-MS/MS) for the absolute quantitation of plasma proteins and peptides facilitates the multiplexed verification of tens to hundreds of biomarkers from smallest sample quantities. Targeted proteomics assays derived from bottom-up proteomics principles rely on the identification and analysis of proteotypic peptides formed in an enzymatic digestion of the target protein. This protocol proposes a procedure for the establishment of a targeted absolute quantitation method for middle- to high-abundant plasma proteins waiving depletion or enrichment steps. Essential topics as proteotypic peptide identification and LC-MS/MS method development as well as sample preparation and calibration strategies are described in detail.
越来越多的肽和蛋白质生物标志物候选物需要快速且可靠的定量策略。利用液相色谱与四极杆串联质谱联用(LC-MS/MS)对血浆蛋白和肽进行绝对定量,有助于从最小量的样本中对数十至数百种生物标志物进行多重验证。源自自下而上蛋白质组学原理的靶向蛋白质组学分析依赖于对目标蛋白酶解形成的蛋白型肽段的鉴定和分析。本方案提出了一种建立针对中高丰度血浆蛋白的靶向绝对定量方法的程序,无需进行去除或富集步骤。详细描述了诸如蛋白型肽段鉴定、LC-MS/MS方法开发以及样品制备和校准策略等重要主题。